The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Never miss any important news. Subscribe to our newsletter.
Never miss any important news. Subscribe to our newsletter.
Recent News
‘Midnight Family’ Is a Fresh and Energetic Medical Drama
November 23, 2024
Listeria Outbreak Kills One, Prompts Recall for Yu Shang Food
November 23, 2024
Chuck Scarborough to Step Down as WNBC News Anchor After 50-Year Career
November 23, 2024
Sebastian Gorka to Return to White House as Adviser
November 23, 2024
‘Carl the Collector’ Puts an Autistic Child (Well, Raccoon) in the Lead
November 23, 2024
Why Matt Gaetz Called His Attorney General Bid a ‘Distraction’
November 23, 2024
Alice Brock, Restaurant Owner Made Famous by a Song, Dies at 83
November 23, 2024